NOVAVAX INC (NVAX) › RevenueNOVAVAX INC (NVAX) — RevenueAnnual figures by fiscal year, from SEC filings.2010: $343.0K2011: $14.69M2012: $22.08M2013: $20.91M2014: $30.66M2015: $36.25M2016: $15.35M2017: $31.18M2018: $34.29M2019: $18.66M2020: $475.60M2021: $1.15B2022: $1.98B2023: $983.71M2024: $682.16M2025: $1.12B$1.12B2010Revenue (USD)2025Fiscal YearRevenueChange YoY2025$1.12B+64.7%2024$682.16M-30.7%2023$983.71M-50.4%2022$1.98B+72.9%2021$1.15B+141.0%2020$475.60M+2448.5%2019$18.66M-45.6%2018$34.29M+10.0%2017$31.18M+103.1%2016$15.35M-57.6%2015$36.25M+18.2%2014$30.66M+46.6%2013$20.91M-5.3%2012$22.08M+50.3%2011$14.69M+4182.2%2010$343.0K—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share